Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP718552.RAWLHtpVFATD__FpoTIrMnCsNLqOT2VwoEeF8BbtfGR3w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP718552.RAWLHtpVFATD__FpoTIrMnCsNLqOT2VwoEeF8BbtfGR3w130_assertion type Assertion NP718552.RAWLHtpVFATD__FpoTIrMnCsNLqOT2VwoEeF8BbtfGR3w130_head.
- NP718552.RAWLHtpVFATD__FpoTIrMnCsNLqOT2VwoEeF8BbtfGR3w130_assertion description "[In addition, the sensitivity of BRCA mutation-associated breast cancer to endocrine therapy, platinum chemotherapy, and poly (ADP-ribose) polymerase inhibitors is reviewed.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718552.RAWLHtpVFATD__FpoTIrMnCsNLqOT2VwoEeF8BbtfGR3w130_provenance.
- NP718552.RAWLHtpVFATD__FpoTIrMnCsNLqOT2VwoEeF8BbtfGR3w130_assertion evidence source_evidence_literature NP718552.RAWLHtpVFATD__FpoTIrMnCsNLqOT2VwoEeF8BbtfGR3w130_provenance.
- NP718552.RAWLHtpVFATD__FpoTIrMnCsNLqOT2VwoEeF8BbtfGR3w130_assertion SIO_000772 22157293 NP718552.RAWLHtpVFATD__FpoTIrMnCsNLqOT2VwoEeF8BbtfGR3w130_provenance.
- NP718552.RAWLHtpVFATD__FpoTIrMnCsNLqOT2VwoEeF8BbtfGR3w130_assertion wasDerivedFrom befree-20140225 NP718552.RAWLHtpVFATD__FpoTIrMnCsNLqOT2VwoEeF8BbtfGR3w130_provenance.
- NP718552.RAWLHtpVFATD__FpoTIrMnCsNLqOT2VwoEeF8BbtfGR3w130_assertion wasGeneratedBy ECO_0000203 NP718552.RAWLHtpVFATD__FpoTIrMnCsNLqOT2VwoEeF8BbtfGR3w130_provenance.